coumarin has been researched along with Alcoholic Liver Diseases in 1 studies
2H-chromen-2-one: coumarin derivative
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sotaniemi, EA | 1 |
| Rautio, A | 1 |
| Bäckstrom, M | 1 |
| Arvela, P | 1 |
| Pelkonen, O | 1 |
1 other study available for coumarin and Alcoholic Liver Diseases
| Article | Year |
|---|---|
CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients.
Topics: Administration, Oral; Adult; Aged; Aryl Hydrocarbon Hydroxylases; Capsules; Coumarins; Cytochrome P- | 1995 |